These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7159180)

  • 1. [Therapeutic use of human immunoglobulins in immune deficiencies].
    Touraine JL
    Arch Fr Pediatr; 1982; 39 Suppl 1():569-72. PubMed ID: 7159180
    [No Abstract]   [Full Text] [Related]  

  • 2. The assessment and management of primary antibody deficiency.
    Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
    N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis and treatment of diseases by means of immunoglobulins.
    Barandun S; Skvaril F; Morell A
    Monogr Allergy; 1975; 9():39-60. PubMed ID: 123313
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus on IVIG.
    Lancet; 1990 Aug; 336(8713):470-2. PubMed ID: 1974993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoglobulins and immune deficiency: methods of administration].
    Suarez F
    Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD.
    Berger M
    J Clin Immunol; 2011 Oct; 31(5):924-6. PubMed ID: 21643892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of opsonification in antimicrobial defense and its therapeutic consequences].
    Mondorf AW; Schaffstein A; Fischer M
    Klin Anasthesiol Intensivther; 1976; (12):49-67. PubMed ID: 1029768
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.
    Matsumoto S; Kobayashi N; Gohya N
    Eur J Pediatr; 1981 May; 136(2):167-71. PubMed ID: 6164555
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of intravenous immune globulin in immunodeficiency diseases.
    Buckley RH; Schiff RI
    N Engl J Med; 1991 Jul; 325(2):110-7. PubMed ID: 2052044
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus conference evaluates key issues concerning use of intravenous immune globulin.
    Clin Pharm; 1990 Jul; 9(7):489, 492-3. PubMed ID: 2198122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Educational program for doctors and nurses taking care for primary immunodeficiency patients treated with subcutaneous immunoglobulins].
    Lewandowicz-Uszyńska A; Szaflarska A; Pietrucha B; Tarnowska I
    Pol Merkur Lekarski; 2011 Jun; 30(180):452-7. PubMed ID: 21751558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New immune globulin product.
    FDA Consum; 2006; 40(2):2. PubMed ID: 16671189
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home.
    Ochs HD; Lee ML; Fischer SH; Delson ES; Chang BS; Wedgwood RJ
    J Infect Dis; 1987 Oct; 156(4):652-4. PubMed ID: 3624908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous immunoglobulins in pediatrics].
    Fontán G
    An Esp Pediatr; 1986 Aug; 25(2):77-9. PubMed ID: 3752750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
    Morell A; Barandun S
    Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of Immunoglobulins].
    Franke F
    Ther Ggw; 1972 Apr; 111(4):480-2 passim. PubMed ID: 5029713
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):565-648. PubMed ID: 2794300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?].
    Kluge S; de Heer G; Nierhaus A; Kreymann G
    Internist (Berl); 2007 Nov; 48(11):1297-302, 1304. PubMed ID: 17901939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and therapy using immunoglobulins].
    Heide K; Schwick HG
    Internist (Berl); 1974 Sep; 15(9):465-70. PubMed ID: 4609355
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?
    Baumann U; Miescher S; Vonarburg C
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):83-5. PubMed ID: 25546772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.